Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Yoshifumi Horisawa"'
Autor:
Katsuaki Kato, Norio Nakamura, Hitoshi Niwa, Yoshifumi Horisawa, Chihaya Kakinuma, Nobuhiko Kaga, Shoko Kuroda, Hiroyuki Sato, Satoshi Kajikawa, Hideaki Morishita, Jun-ichi Miyazaki
Publikováno v:
Biochemical and Biophysical Research Communications. 281:1154-1160
Urinary trypsin inhibitor (UTI) is a serine proteinase inhibitor that is found in blood and urine. To investigate the physiological functions of UTI in vivo, we generated UTI-deficient mice by gene targeting. The mice showed no obvious abnormalities
Autor:
Keisuke Sugihara, Hideaki Morishita, Toshinori Kanamori, Hideaki Umeyama, Jiro Hirose, Mitsuko Isaji, Tomokazu Matsusue, Toshihisa Miura, Yoshifumi Horisawa, Toru Yamakawa, Atsushi Nii
Publikováno v:
The Journal of Biochemistry. 115:1107-1112
The second domain (R-020) of human urinary trypsin inhibitor (UTI) exerts similar inhibitory activities on trypsin, alpha-chymotrypsin, leukocyte elastase, and plasmin to those of UTI itself, and additionally inhibits coagulation factor Xa (FXa) and
Autor:
Yoshifumi Horisawa, Tadanori Mayumi, Yasuo Tsutsumi, Toshinori Kanamori, Tetsunari Kihira, Shinsaku Nakagawa, Hakuo Ikegami, Masaharu Miyake, Kazuyoshi Kubo, Susumu Yamamoto
Publikováno v:
Japanese Journal of Cancer Research : Gann
Natural human tumor necrosis factor-alpha (TNF-alpha) was chemically modified with an active ester of monomethoxy polyethylene glycol (PEG). The molecular weight of PEG-modified TNF-alpha depended on the reaction time as well as the initial molar rat
Autor:
Kouichi Noda, Takeshi Kusuyama, Yoshifumi Horisawa, Hiromi Ogino, Tetsuya Asami, Hidemi Ohta, Mitsuko Isaji, Ryo Tanaka
Publikováno v:
Japanese Journal of Thrombosis and Hemostasis. 2:461-468
Purified natural human fibroblast-derived interleukin-6 (nhlL-6) was obtained from a culture of a normal human fibroblast cell strain, and its effect on the platelet number in normal mice was examined.The platelet number in female BDF1 mice given sub
Autor:
Yoshifumi Horisawa, Shinsaku Nakagawa, Yoshihisa Kaneda, Tetsunari Kihira, Yasuo Tsutsumi, Shin-ichi Tsunoda, Yoko Yamamoto, Tadanori Mayumi, Haruhiko Kamada
Publikováno v:
Biochemical and biophysical research communications. 257(2)
We conjugated tumor necrosis factor-alpha (TNF-alpha) with the synthetic polymeric modifier polyvinyl pyrrolidone (PVP) to facilitate its clinical use for anti-tumor therapy. TNF-alpha was chemically conjugated with the terminal carboxyl-bearing PVP
Publikováno v:
Journal of interferoncytokine research : the official journal of the International Society for Interferon and Cytokine Research. 18(9)
We studied the effects of oral-mucosal administration of murine interferon-alpha (Mu-IFN-alpha) on immune responses and infection with vaccinia virus (VV) in mice. When Mu-IFN-alpha was administered to sheep red blood cell (SRBC)-sensitized mice for
Autor:
Tetsunari Kihira, Haruhiko Kamada, Yasuo Tsutsumi, Yoshihisa Kaneda, Yoko Yamamoto, Yoshifumi Horisawa, Tadanori Mayumi, Shin-ichi Tsunoda, Shinsaku Nakagawa
Publikováno v:
Japanese Journal of Cancer Research : Gann
We previously reported that the optimally PEGylated tumor necrosis factor-alpha (MPEG-TNF-alpha), in which 56% of the TNF-alpha-lysine amino groups were coupled with polyethylene glycol (PEG), had about 100-fold greater anti-tumor effect than native
Autor:
Yoshifumi Horisawa, Masahiro Nobuhara, Kazuharu Kato, Masashi Kurimoto, Meroni Imai, Yasuo Tanaka, Norio Nakamura, Tetsuya Asami, Yoshitaka Hosaka, Toshinori Kanamori, Yoshikazu Ashida
Publikováno v:
Japanese Journal of Cancer Research : Gann
We have investigated the in vivo antitumor mechanism of natural human tumor necrosis factor (n‐TNF) isolated from a culture of human leukemic B cell line (BALL‐1), especially its action as an immunomodulator, and found that the in vivo antitumor
Publikováno v:
Blood & Vessel. 18:278-281
Publikováno v:
Blood & Vessel. 18:464-470
The in vitro and in vivo combined effects of urinary plasminogen activator (u-PA) and tissue plasminogen activator (t-PA) were examined. In in vitro experiments the additive combined effects of u-PA and t-PA were observed on human plasma clot lysis.